Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph N Contessa

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Molecular Pharmacology|November 6, 2007
Revoking the privilege: targeting HER2 in the central nervous systemJoseph N Contessa, Daniel A Hamstra
Cancer Journal (Sudbury, Mass.)|September 27, 2022
STING Agonists in Head and Neck Squamous Cell CarcinomaDavid G Wallington, Joseph N Contessa, Thomas J Hayman
Glycoconjugate Journal|April 20, 2018
MPDU1 regulates CEACAM1 and cell adhesion in vitro and in vivoDaniel C Bennett, Aurelie Cazet, Jon Charest, et al.
Cancer Journal (Sudbury, Mass.)|September 22, 2015
Lung Cancer Brain MetastasesSarah B Goldberg, Joseph N Contessa, Sacit B Omay, et al.
Plos One|October 15, 2014
Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivityAurélie Cazet, Jonathan Charest, Daniel C Bennett, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2019
Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunctionHua Lu, Natalia A Cherepanova, Reid Gilmore, et al.
Cancer Research|May 17, 2008
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cellsJoseph N Contessa, Mahaveer S Bhojani, Hudson H Freeze, et al.
Analytical Biochemistry|June 23, 2011
Molecular imaging of epidermal growth factor receptor kinase activityAmjad P Khan, Joseph N Contessa, Mukesh K Nyati, et al.
Oncogene|August 30, 2003
ERBB receptor tyrosine kinases and cellular radiation responsesRupert K Schmidt-Ullrich, Joseph N Contessa, Guido Lammering, et al.
Molecular Cancer Therapeutics|August 8, 2019
Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaMarta Baro, Cecilia Lopez Sambrooks, Barbara A Burtness, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Molecular Pharmacology|November 6, 2007
Revoking the privilege: targeting HER2 in the central nervous systemJoseph N Contessa, Daniel A Hamstra
Cancer Journal (Sudbury, Mass.)|September 27, 2022
STING Agonists in Head and Neck Squamous Cell CarcinomaDavid G Wallington, Joseph N Contessa, Thomas J Hayman
Glycoconjugate Journal|April 20, 2018
MPDU1 regulates CEACAM1 and cell adhesion in vitro and in vivoDaniel C Bennett, Aurelie Cazet, Jon Charest, et al.
Cancer Journal (Sudbury, Mass.)|September 22, 2015
Lung Cancer Brain MetastasesSarah B Goldberg, Joseph N Contessa, Sacit B Omay, et al.
Plos One|October 15, 2014
Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivityAurélie Cazet, Jonathan Charest, Daniel C Bennett, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2019
Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunctionHua Lu, Natalia A Cherepanova, Reid Gilmore, et al.
Cancer Research|May 17, 2008
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cellsJoseph N Contessa, Mahaveer S Bhojani, Hudson H Freeze, et al.
Analytical Biochemistry|June 23, 2011
Molecular imaging of epidermal growth factor receptor kinase activityAmjad P Khan, Joseph N Contessa, Mukesh K Nyati, et al.
Oncogene|August 30, 2003
ERBB receptor tyrosine kinases and cellular radiation responsesRupert K Schmidt-Ullrich, Joseph N Contessa, Guido Lammering, et al.
Molecular Cancer Therapeutics|August 8, 2019
Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaMarta Baro, Cecilia Lopez Sambrooks, Barbara A Burtness, et al.
Pageof 7